Auriga Laboratories Announces FDA Approval Of Liquadd TM Oral Solution For The Treatment Of ADHD And Upcoming Product Launch

Auriga Laboratories, Inc. (OTCBB: ARGA), a specialty pharmaceutical company, announced today the FDA approval of Liquadd™ (dextroamphetamine sulfate) Oral Solution 5 mg/5 mL indicated for the treatment of Attention Deficit Disorder with Hyperactivity (ADHD).

Increased Risk For Eating Disorders Found In Adolescent Girls With ADHD

Girls with attention deficit hyperactivity disorder stand a substantially greater risk of developing eating disorders in adolescence than girls without ADHD, a new study has found."Adolescent girls with ADHD frequently develop body-image dissatisfaction and may go through repeating cycles of binge eating and purging behaviors that are common in bulimia nervosa, " said University of Virginia psychologist Amori Yee Mikami, who led the study.

Studying ADHD In Youth Of Different Races

The research in the article looked at childhood ADHD in underrepresented minorities, reviewing controversy around evaluation, diagnosis, and obstacles faced by families, ending with recommendations for assessment and treatment.

Young Hyperactive Girls More Likely To Have Serious Problems As Adults

Young girls who are hyperactive are more likely to get hooked on smoking, under-perform in school or jobs and gravitate towards mentally abusive relationships as adults, according to a joint study by researchers from the Universit~A de Montr~A al and the University College London (UCL).

Encouraging Preschool Kids To Talk To Themselves

Parents should not worry when their pre-schoolers talk to themselves; in fact, they should encourage it, says Adam Winsler, an associate professor of psychology at George Mason University. His recent study published in Early Childhood Research Quarterly showed that 5-year-olds do better on motor tasks when they talk to themselves out loud (either spontaneously or when told to do so by an adult) than when they are silent.

Stimulant Treatment For Young Children With ADHD Does Not Lead To Increased Risk Of Substance Abuse In Early Adulthood

Treatment of children with stimulant medications for attention-deficit/hyperactivity disorder (ADHD) does not increase the risk of substance abuse later in adolescence and early adulthood.

Night-Time Acid Reflux Can Impact Sleep, New Studies Reveal

According to results of a survey presented at the 72nd Annual Scientific Meeting of the American College of Gastroenterology, nighttime acid reflux, along with some of the less typical manifestations or symptoms of gastroesophageal reflux disease (GERD), is associated with significant sleep impairment.

Survey Reveals Heartburn Sufferers Experience More Heartburn During The Holidays

Heartburn remains a burning problem for more than 60 million Americans each month(1), and this November, the National Heartburn Alliance (NHBA) is recognizing the need for heartburn education by sponsoring the first ever Heartburn Awareness Month. Recent survey results show that 66% of people experience heartburn symptoms during the holiday season.

Wyeth Receives FDA Approval Of Protonix For Delayed Release Oral Suspension

Wyeth Pharmaceuticals, a division of Wyeth (NYSE:WYE), announced that the U.S. Food and Drug Administration (FDA) has approved Protonix (pantoprazole sodium) For Delayed-Release Oral Suspension, a new addition to the Protonix family of prescription medications.

Astrazeneca Receives First European Approval For Nexium R In Pediatric Gerd

AstraZeneca announced that it has received Swedish Medical Products Agency (MPA) approval for use of Nexium(R) (esomeprazole) in children aged 1-11 years with gastroesophageal reflux disease (GERD) in the reference member state of Sweden, with other European Union nations expected to follow.